<DOC>
	<DOCNO>NCT01128725</DOCNO>
	<brief_summary>Beta amyloid immunoreactivity probably due significant number Ab catabolites correspond N-terminally truncate Cterminally truncate extended form display distinct propensity aggregation . Very thing know concern mechanism protease generate . Furthermore , link truncation toxicity delineate . Finally , little known concern Ab fragment biological fluid whether could see early biomarkers thereby , putative target AD diagnostic . The present project allow examine human biological sample identify various cohort complete clinical evaluation .</brief_summary>
	<brief_title>Truncated Extended Forms Amyloid Beta Peptides Alzheimer 's Disease : Genesis , Toxicity Identification Biological Markers</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<criteria>1 ) Coming subject see patient CMRR complaint mn√©sique 2 ) Introducing score Tiny Mental upper Test ( MMSE ) 28/30 without error score recall 3 word 3 ) Introducing score 10/10 test 5 word B2C 4 ) Introducing score ladder CDR ( Clinical Dementia Rating ) equal 0 5 ) Having give lit consent 6 ) Being affiliated member beneficiary regime French national health pension organization Major , vulnerable person 18 tutelage , legal guardianship , deprive freedom , hospitalize health Establishment social quite reason search Record neurological psychiatric pathology inability sensory reason perform cognitive balance sheet</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2010</verification_date>
</DOC>